Discussion
Diagnosis With Brief Discussion
- Diagnosis
- Pleuroparenchymal fibroelastosis
- Radiologic Findings
- Figs 1-2. Chest PA and lateral view show increased reticular opacities in both lungs and marked apical pleural thickening.
Fig 3-6. Lung window setting of the chest CT scan shows pleural and subpleural thickening with severe fibrotic changes in the marginal parenchyma with apicocaudal distribution.
Figs 7-9. Coronal reformatted images show marked apical pleural thickening, volume loss of the upper lungs, and peripheral consolidation. Note the evolution between 2014 and 2016 (at the time of diagnosis).
- Brief Review
- She underwent VATS biopsy, and pathologic findings revealed subpleural dense fibrosis with elastosis and patchy lymphocytic infiltration, suggesting pleuroparenchymal fibroelastosis (PPFE). Her sister was also diagnosed with the same disease.
PPFE is a rare entity that has been recently included in the official American Thoracic Society/European Respiratory Society (ATS/ERS) statement in 2013 as a group of rare idiopathic interstitial pneumonias (IIPs). PPFE is characterized by pleural and subpleural parenchymal thickening due to elastic fiber proliferation, mainly in the upper lobes. Pathologically, interstitial fibrosis takes the form of a dense consolidation with some preservation of alveolar septal outlines and demonstrates a distinctly abrupt interface with residual normal lung. Unrecognized cases of PPFE may be incorrectly diagnosed as sarcoidosis, atypical idiopathic pulmonary fibrosis, or other unclassifiable interstitial pneumonias.The etiology of the disease is unclear, although some cases have been associated as a complication after bone marrow transplantation, lung transplantation, chemotherapy, and recurrent respiratory infections. The patients usually report progressive dyspnea and dry cough; pBetter awareness of the disease with its clinical and radiologic features can help with optimal management by the multidisciplinary team. Clinical outcome in PPFE is variable with a significant number of patients demonstrating progressive decline and death. Survival characteristics depend on the stage of the disease at presentation. Aside from lung transplantation, there is no demonstrated effective treatment.
Radiological differential diagnoses may include chronic hypersensitivity pneumonitis, atypical usual interstitial pneumonitis, collagen vascular diseases, irradiation injury, asbestos exposure, prominent apical cap fibrosis, and sarcoidosis.
- References
- 1. Reddy TL, Tominaga M, Hansell DM, et al. Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes. Eur. Respir. J. 2012;40:377–385.
2. Frankel SK, Cool CD, Lynch DA, et al. Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity. Chest. 2004;126:2007–2013.
3. Travis WD, Costabel U, Hansell DM et-al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2013;188 (6): 733-48.
- Keywords
- Lung, Pleura,